Please use this identifier to cite or link to this item: https://ninho.inca.gov.br/jspui/handle/123456789/15482
Full metadata record
DC FieldValueLanguage
dc.contributor.authorInstituto Nacional de Câncer José Alencar Gomes da Silva-
dc.contributor.authorInstituto Nacional de Câncer (Brasil)-
dc.contributor.authorINCA-
dc.date.accessioned2024-02-26T21:12:10Z-
dc.date.available2024-02-26T21:12:10Z-
dc.date.issued2003-12-
dc.identifier.urihttps://ninho.inca.gov.br/jspui/handle/123456789/15482-
dc.descriptionp. 2.: il. p&b.pt_BR
dc.language.isoporpt_BR
dc.publisherINCApt_BR
dc.subjectLinfomapt_BR
dc.subjectLymphomapt_BR
dc.subjectTerapêuticapt_BR
dc.subjectTherapeuticspt_BR
dc.subjectTerapéuticapt_BR
dc.titleNovas terapêuticas no tratamento de linfomapt_BR
dc.title.alternativeInforme INCA 161pt_BR
dc.TypeArticlept_BR
Appears in Collections:Informe INCA 161

Files in This Item:
File Description SizeFormat 
Informe_INCA_161-2-Novas-terapêuticas-no.pdf674.96 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.